Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015

Be the first to review this product

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals -...
You can choose to pay by purchase order during checkout

Availability: In stock

$1,500.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015' report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q4 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the five quarters.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include _ North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 148
Publication date 11 Feb 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 12
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2015 16
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2015 16
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2015 19
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2015 20
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2015 21
2.4.1 Allergan and Pfizer to Combine in USD160 Billion Deal 21
2.4.2 Shire Acquires Dyax 22
2.4.3 AstraZeneca Prices Public Offering of Notes for USD6 Billion 23
2.4.4 Sanofi to Enter into Licensing Agreement with Hanmi Pharma 23
2.4.5 AstraZeneca Acquires 55% Stake in Acerta Pharma 24
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 25
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2015 25
3.1.1 Top M&A Deals in Q4 2015 26
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2014 - Q4 2015 27
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2015 29
3.2.1 Top Initial Public Offerings in Q4 2015 30
3.2.2 Top Secondary Offerings in Q4 2015 31
3.2.3 Top PIPE Deals in Q4 2015 31
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2014-Q4 2015 31
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2014 - Q4 2015 32
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q4 2015 34
3.3.1 Top Venture Financing Deals in Q4 2015 35
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2015 36
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2015 37
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2014 - Q4 2015 38
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q4 2014 - Q4 2015 40
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q4 2014 - Q4 2015 42
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2015 43
3.4.1 Top Private Equity Deals in Q4 2015 44
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2014 - Q4 2015 45
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2015 47
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2015 47
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2014 - Q4 2015 49
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2015 51
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2015 52
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2015 53
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2015 53
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2014 - Q4 2015 54
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2014 - Q4 2015 56
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2014 - Q4 2015 57
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2014 - Q4 2015 59
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2015 61
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2015 61
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2014 - Q4 2015 63
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2015 64
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2015 65
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2015 65
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2014 - Q4 2015 66
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2014 - Q4 2015 68
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2014 - Q4 2015 70
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2014 - Q4 2015 71
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2014 - Q4 2015 73
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 75
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2014 - Q4 2015 75
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2014 - Q4 2015 77
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2014 - Q4 2015 78
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2014 - Q4 2015 80
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2014 - Q4 2015 82
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2014 - Q4 2015 84
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 86
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2015 86
7.1.1 Oncology - Deals of the Quarter 88
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2015 91
7.2.1 Central Nervous System - Deals of the Quarter 93
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2015 95
7.3.1 Infectious Disease - Deals of the Quarter 97
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2015 99
7.4.1 Immunology - Deals of the Quarter 101
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2015 104
7.5.1 Metabolic Disorders - Deals of the Quarter 106
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2015 108
7.6.1 Cardiovascular - Deals of the Quarter 110
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2015 112
7.7.1 Gastrointestinal - Deals of the Quarter 114
7.8 Pharmaceuticals & Healthcare, Global, Hematological Disorders Deals, Q4 2015 116
7.8.1 Hematological Disorders - Deals of the Quarter 117
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2015 119
7.9.1 Respiratory - Deals of the Quarter 120
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2015 122
7.10.1 Dermatology - Deals of the Quarter 124
8 Deal Summary by Geography 125
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2015 125
8.1.1 North America - Deals of the Quarter 127
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2015 129
8.2.1 Europe - Deals of the Quarter 131
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2015 133
8.3.1 Asia-Pacific - Deals of the Quarter 135
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2015 136
8.4.1 Rest of the World - Deals of the Quarter 138
9 Pharmaceuticals & Healthcare, Global, Top Advisors 139
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q4 2014 - Q4 2015 139
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q4 2014 - Q4 2015 141
10 Appendix 143
11 Further Information 145
11.1 Methodology 145
11.2 About GlobalData 146
11.3 Disclosure information 146
11.4 Disclaimer 147

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.